Agilon Health Inc. (NYSE: AGL) reported Q3 EPS of ($0.07), $0.02 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $695 million versus the consensus estimate of $652.82 million.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.